Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PG 31:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003661 AN006018 Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period Blood Human Cardiovascular disease Zhongshan Hospital Fudan University LC-MS
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University LC-MS
ST002890 AN004748 Characterization of the in vivo deuteration of native phospholipids by mass spectrometry yields guidelines for their regiospecific customization Bacterial cells Escherichia coli University of Tennessee LC-MS
ST001859 AN003013 dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin Insect tissue Fruit fly VIB-KU Leuven MS(Dir. Inf.)
ST001859 AN003014 dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin Insect tissue Fruit fly VIB-KU Leuven MS(Dir. Inf.)
ST001796 AN002918 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib Mesenteric lymph Mouse Diabetes Monash Institute of Pharmaceutical Sciences LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
  logo